Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to -$4.1 million.

  • Traws Pharma's Net Cash Flow rose 6450.85% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 11178.19%. This contributed to the annual value of $536000.0 for FY2024, which is 10298.67% up from last year.
  • Latest data reveals that Traws Pharma reported Net Cash Flow of -$4.1 million as of Q3 2025, which was up 6450.85% from -$2.9 million recorded in Q2 2025.
  • Traws Pharma's 5-year Net Cash Flow high stood at $29.0 million for Q1 2021, and its period low was -$11.5 million during Q3 2024.
  • Moreover, its 5-year median value for Net Cash Flow was -$4.3 million (2021), whereas its average is -$1.1 million.
  • In the last 5 years, Traws Pharma's Net Cash Flow soared by 61484.4% in 2021 and then crashed by 15679.12% in 2024.
  • Traws Pharma's Net Cash Flow (Quarter) stood at -$4.3 million in 2021, then increased by 9.67% to -$3.9 million in 2022, then fell by 14.06% to -$4.4 million in 2023, then skyrocketed by 459.75% to $15.9 million in 2024, then plummeted by 125.56% to -$4.1 million in 2025.
  • Its last three reported values are -$4.1 million in Q3 2025, -$2.9 million for Q2 2025, and -$5.4 million during Q1 2025.